Senores Pharmaceuticals Limited is all set to hit the market with its Initial Public Offering (IPO) on December 20, 2024. The IPO, with a price band of ₹372 to ₹391 per share, aims to raise approximately ₹582.11 crore. The grey market is buzzing with activity, and as of today, the Senores Pharmaceuticals IPO Grey Market Premium stands at ₹125. This suggests a potential listing price of ₹516 per share, translating to an impressive 30% gain over the upper price band.
If you’re considering this IPO, here’s everything you need to know about Senores Pharmaceuticals, from the IPO details to the company’s financials and whether it’s worth investing in.
Senores Pharmaceuticals IPO Grey Market Premium Today
The GMP is a crucial indicator of market sentiment for an IPO before its listing. For Senores Pharmaceuticals, the premium of ₹125 reflects positive investor sentiment and high demand. While a strong GMP is encouraging, remember that it is subject to fluctuations and should be considered alongside the company’s fundamentals.
Senores Pharmaceuticals IPO Details
| Particulars | Details |
|---|---|
| Issue Size | ₹582.11 crore (Fresh Issue: ₹500 crore, OFS: 21 lakh shares) |
| Price Band | ₹372 to ₹391 per share |
| Lot Size | 38 shares (₹14,858 minimum investment) |
| IPO Type | Book-built issue |
| Quota Allocation | QIB: 75%, NII: 15%, RII: 10% |
| IPO Open Date | December 20, 2024 |
| IPO Close Date | December 24, 2024 |
| Allotment Finalization Date | December 27, 2024 |
| Refunds Initiated | December 28, 2024 |
| Demat Credit Date | December 29, 2024 |
| Listing Date | December 30, 2024 |
About Senores Pharmaceuticals
Founded in 2017, Senores Pharmaceuticals Limited has made a name for itself as a global player in the pharmaceutical sector. The company focuses on manufacturing a wide range of medications, including Amphetamine Sulfate Tablets and Ketoconazole Tablets, targeting regulated markets like the US, UK, and Canada, while also expanding into emerging markets.
Senores Pharmaceuticals operates on a B2B model, supplying high-quality medicines to prominent players in the global pharmaceutical industry. Its strong foothold in regulated markets is a testament to its robust compliance and product quality standards.
Financial Performance
While specific financial results are not detailed here, potential investors should examine the company’s profitability, revenue growth, and debt levels through its IPO prospectus. A clear understanding of financials will help in making a well-informed decision.
| Particulars | FY 2021-22 | FY 2022-23 | FY 2023-24 | H1 FY 2024-25 (up to September 30, 2024) |
|---|---|---|---|---|
| Revenue from Operations | ₹14.17 crore | ₹35.34 crore | ₹214.52 crore | ₹181.02 crore |
| Profit After Tax (PAT) | ₹0.99 crore | ₹8.43 crore | ₹32.71 crore | ₹23.94 crore |
Should You Apply for Senores Pharmaceuticals IPO?
The IPO’s GMP of ₹125 indicates strong demand and the potential for significant listing gains. Additionally, the company’s presence in regulated markets and its solid growth trajectory make it an attractive investment option.
However, investing in an IPO should never rely solely on grey market trends. Investors are encouraged to assess the company’s fundamentals, such as its operating model, financial health, and market potential. Consulting with a financial advisor before making a decision is always a good idea.
Pravin Bhosale
I am finance blogger with a Bachelor’s degree in Electrical Engineering. Since stepping into the world of trading in 2019, i have gained valuable experience navigating the markets, have knowldge in indices like Bank Nifty, Nifty IT, Sensex, Bankex, and Finifty. our blog aims to make finance approachable, offering practical insights for readers to better understand and act on market trends.
Top 5 FAQs About Senores Pharmaceuticals IPO
- What is the price band for the IPO?
The price band is ₹372 to ₹391 per share. - When does the IPO open and close?
The IPO opens on December 20, 2024, and closes on December 24, 2024. - What is the grey market premium today?
As of December 19, 2024, the GMP is ₹125 per share. - What is the minimum investment required?
You can invest with a minimum of ₹14,858, which covers one lot of 38 shares. - How is the issue size structured?
The total issue size is ₹582.11 crore, which includes a fresh issue of ₹500 crore and an OFS of 21 lakh shares.